Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy — Yuval Dor (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy
Shared by
Peter Carmeliet
Aarhus University
Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy
Article
2002
en
Authors
+5 more
YD
Yuval Dor
VD
Valentin Djonov
RA
Rinat Abramovitch
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Preprint
2019
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides new insights into the genetics of type 1 diabetes
Mireia Ramos-Rodríguez
,
Helena Raurell‐Vila
,
ML. Colli
,
MI. Alvelos
,
Montserrat Subirana
,
Jonàs Juan‐Mateu
,
Russell A. Norris
,
J-V. Turatsinze
,
ES. Nakayasu
,
BJ. Webb-Robertson
,
JRJ. Inshaw
,
Piero Marchetti
,
Lorenzo Piemonti
,
Manel Esteller
,
JA. Todd
,
TO. Metz
,
DL. Eizirik
,
Lorenzo Pasquali
Article
2006
New Strategies for Cardiovascular Gene Therapy: Regulatable Pre-Emptive Expression of Pro-Angiogenic and Antioxidant Genes
Jozef Dulak
,
Anna Zagórska
,
Barbara Wegiel
,
Agnieszka Łoboda
,
Alicja Józkowicz
Article
2009
Pathway Analysis of GWAS Provides New Insights into Genetic Susceptibility to 3 Inflammatory Diseases
Hariklia Eleftherohorinou
,
Victoria Wright
,
Clive Hoggart
,
Anna‐Liisa Hartikainen
,
Paul M Ridker
,
David J. Balding
,
Lachlan Coin
,
Michael Levin
Article
2009
Pathway Analysis of GWAS Provides New Insights into Genetic Susceptibility to 3 Inflammatory Diseases
Hariklia Eleftherohorinou
,
Victoria Wright
,
Clive Hoggart
,
Anna‐Liisa Hartikainen
,
Paul M Ridker
,
David J. Balding
,
Lachlan Coin
,
Michael Levin
Preprint
2020
Functional pangenome analysis provides insights into the origin, function and pathways to therapy of SARS-CoV-2 coronavirus
Intikhab Álam
,
Allan Kamau
,
Maxat Kulmanov
,
Stefan T. Arold
,
Arnab Pain
,
Takashi Gojobori
,
Carlos M. Duarte
Discussion(0)
No comments yet. Be the first to comment.